---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-155416"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T13:16:46.786575+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Vor Biopharma stockholders elect Lubner and Resnick as Class II directors, ratify EY as auditor

## Summary
- David C. Lubner elected with 53,754,258 votes for, 45,048 withheld (4,500,866 broker non-votes).
- Joshua Resnick, M.D. elected with 44,270,251 votes for, 9,529,055 withheld (4,500,866 broker non-votes).
- Ratification of Ernst & Young as independent auditor for FY2023 approved: 58,294,758 for, 1,908 against, 3,506 abstentions.
- Approximately 87% of outstanding shares (58.3M) represented at the meeting.

## SEC filing metadata
- accession: 0001193125-23-155416
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312523155416/0001193125-23-155416-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312523155416/d436577d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-155416
- JSON: https://secwatch.observer/filing/0001193125-23-155416.json
- Plain text: https://secwatch.observer/filing/0001193125-23-155416.txt

## Key facts
- Shareholder Votes
  Vor Biopharma Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2023-05-26 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-26
  source text: Proposal 2 – Ratification of Selection of Independent Registered Public Accounting Firm The stockholders ratified the selection by the Audit Committee of the Board of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023, by the following votes: Votes For Votes Against Abstentions 58,294,758 1,908 3,506
  evidence_url: https://www.sec.gov/Archives/edgar/data/1817229/000119312523155416/0001193125-23-155416-index.htm
- Shareholder Votes
  Vor Biopharma Inc. shareholders approved Election of Two Class II Directors David C. Lubner and Joshua Resnick, M.D. at the 2023-05-26 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-26
  source text: by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes David C. Lubner 53,754,258 45,048 4,500,866 Joshua Resnick, M.D. 44,270,251 9,529,055 4,500,866
  evidence_url: https://www.sec.gov/Archives/edgar/data/1817229/000119312523155416/0001193125-23-155416-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.